ABT-116 is an orally active antagonist of transient receptor potential vanilloid type 1 (TRPV1). ABT-116 has analgesic efficacy. ABT-116 can be used for the research of neurological disease[1].
Molecular Weight:
432.48
CAS Number:
[1008529-42-7]
Formula:
C23H27F3N4O
Target:
TRP Channel
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted